PADI4 and Schnyder corneal dystrophy: We present herein several novel key conceptual findings and the first direct evidence that targeting PAD4 and NOX (two key neutrophil enzymes involved in innate immunity and disease) attenuates murine cerebrovascular inflammation and modifies neutrophil behaviour in human neutrophils, including SCD, towards an anti-thromboinflammatory phenotype.